relatively short time of patent protection. The reality is that, just as the most dangerous part of an aircraft flight is at take off (and landing), so is a drug generally most dangerous in its first year or so of clinical use. Benoxaprofen made the headlines largely because hundreds of thousands of patients were prescribed the drug in that dangerous first year. It may be a statement of the obvious that had fewer patients taken benoxaprofen fewer would have been damaged,5 but scandals are made by numbers.
As we have argued before, ways must be found to set some limit to the uptake of drugs in their first year or so on the market (with a compensatory extension of patent life).5 More important, any doctor who makes the clinical decision to use a new drug should recognise that by so doing he is under an ethical obligation to keep full notes and record and report any adverse event, whether or not it seems likely to be linked with the drug. Doctors should not expect payment for that record keeping; indeed, if they do not keep such records they are, in our view, negligent.
These arguments have been rehearsed before. The new feature of the drug debate is its emphasis on advertising and promotion. Some doctors, at least, recognise that their professional image is being tarnished by their apparent financial thralldom to the pharmaceutical industry-and the industry is beginning to see that its own image needs to be improved if politicians are to be restrained from trying to control or curb expenditure on promotion.
What are the causes for concern ? Complaints about drug advertising in journals and by direct mail are mostly confined to the frequency and numbers of these advertisements. Recent attempts by some companies to promote drugs by feeding information directly to the public have been heavily criticised and seem unlikely to be repeated. More serious doubts are raised by the close links between the pharmaceutical industry and the design and analysis of clinical trials of its products and by publication of reports of drug research in journals with no system of peer review. And what has angered the consumer watchdogs are the drug company sponsored concerts, banquets, and excursions. How has the medical profession come to expect that not only should its postgraduate education be financed by an interested partythe drug industry-but that the industry should also pay for much of doctors' foreign travel and entertainment?
Surely the time has come for the medical profession and the pharmaceutical industry to extend the agreed code of practice6 by setting reasonable boundaries for expenditure on drug promotion? A joint, non-governmental, committee might be set up to provide guidance and possibly to hear complaints. The industry could do much to refurbish its own image by establishing a foundation independent of any individual company to help finance research studies of the safety and efficacy of drugs. The more extravagant promotional activities should, we believe, no longer be seen as acceptable. It is up to individual doctors to make that plain. ' 42 patients all of whom were ready to submit to surgery. Only four ofthese eventually had an operation, all because of persistent soreness and irritation from the lotion. '1 But if axillary hyperhidrosis can now be dealt with fairly well, with an effective and safe operation available for the minority of patients who cannot tolerate the aluminium chloride mixture, the same cannot be said for palmar sweating. Clearly conservative measures should be used if possible, but the results of using both tranquillisers and systemic anticholinergics, with all their side effects, have usually been disappointing. In the past topical applications have not had much success either, but there have recently been reports of good results with methenamine (hexamine)14 and with nightly applications of the alcoholic aluminium chloride hexahydrate mixture.'5 This general failure of topical applications led to efforts to drive the chemicals into the skin electrically with iontophoresis and to the surprising finding that ordinary tap water acts almost as well as any of these solutions and at the same time avoids systemic side effects. Levit has given a clear account of the practical details of tap water iontophoresis.'6 Once a reduction in sweating has been obtained treatment every few weeks may suffice, and patients may then avoid endless trips to hospital by acquiring a simple and effective apparatus to use themselves at home.
Other techniques such as biofeedback and conditioning17 are still in their infancy but may offer some hope in the future. At present, however, if a fair trial of the above methods has not helped then sympathectomy should be considered. An operation which may require exploration through important deep structures in the neck or the removal of parts of the ribs should never be undertaken lightly. Various surgical approaches are available, but the supraclavicular route seems to carry an especially high risk of causing Horner's syndrome,3 and Kux's endoscopic technique4 is perhaps the least traumatic. Sympathectomy denervates the sweat glands not just of the palm but of up to one fifth of the body surface,'8 and compensatory sweating in other areas may become a problem. Despite this, patients relieved of their wet hands are kind about the operation, and the long term results are usually satisfactory. 
Locking up patients with psychiatric illness
Most inpatients with psychiatric illness are treated in open wards,' but for a time a few may be nursed in seclusion.2 The latter is defined as the containment of a patient alone in a room or enclosed area from which he has no way out3 4; today such restraint is used in psychiatric hospitals,5 secure units,6 and special hospitals.7
Seclusion is carried out in two main circumstances: firstly, in an emergency to help cope with disturbed behaviour; and, secondly, and probably much less commonly, with the patient's consent in behaviour modification programmes.48 Occasionally, however, there is no clear cut difference between these two activities, but whatever the reason the result is that an ill person may be isolated from human contact in a bare room for an unspecified period. Although prison rules govern removal from association and the use of solitary confinement, there is no statutory control of these procedures in the National Health Service. Moreover, 
